A novel approach to sweetening foods and beverages using approximately 100 identified volatile compounds that enhance sweetness perception. By combining multiple volatiles, their individual flavors suppress each other, creating effective sweetness enhancement with minimal or no detectable flavor at low concentrations using GRAS ingredients.
This research presents a novel sweetness enhancement technology based on approximately 100 volatile compounds that amplify the perceived sweetness of sugars and artificial sweeteners. The core innovation lies in combining multiple sweetness-enhancing volatiles so that their individual flavors cancel each other out, similar to how smells suppress one another in mixtures. This results in a sweetener system that delivers enhanced sweetness without introducing unwanted flavor notes. Because the volatiles can be selected from GRAS (Generally Recognized as Safe) ingredients and used at very low concentrations, the approach offers a safe method for sweetening foods and beverages.
This technology is at an early-to-mid stage of development. Pilot data has demonstrated sweetness enhancement by adding appropriate volatiles to small amounts of sweetener. Laboratory work in the Sobel lab has shown cancellation of volatile smells in mixtures, and pilot data indicates similar cancellation occurs when volatiles are perceived as flavors. Additionally, pilot data shows that the perceived flavor intensity of 55 volatiles is lower than some of their individual components. Future validation efforts will systematically demonstrate flavor suppression among volatiles, determine the relationship between the number of volatiles and degree of suppression, apply psychophysical methodology to identify individual differences, and continue expanding the library of sweetness-enhancing volatiles.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.